Philips India, a global health technology and innovative company, recently unveiled the new Azurion system to specialist interventionalists in cardiology, neurology, vascular, and surgical care across India. Intended for neurovascular care, Azurion improves the speed at which clinical decisions are made, which is beneficial for both the patient and the clinical team. These additional elements include better C-arm rotation and angulation to reach imaging angles, parking options to switch between 2D and 3D very quickly while not moving the imager, and extensive table-side control options to preserve sterility. Additionalities are automatic beam rotation for the correct origin of images with any angulation and a new head immobilizer to improve the stroke treatment.
Philips also broadens the portfolio of its Angio suite solutions through the integration of the new remote connection services of the Philips Service Hub based on AI and machine learning. These services track system health, learn potential service problems, and bring about a means for corrective steps to reduce downtime.
The Azurion system, which has been installed at Philips Innovation Campus in Bangalore – the largest Philips facility for innovation across the world- was recently demonstrated to 80 interventionalists across India. “At Philips India, we are committed to advancing health technology to improve lives and healthcare outcomes across the country. The new Azurion empowers our customers to transform how patients are treated for a broad range of critical illnesses, including cardiovascular and neurovascular diseases. Philips, through its significant investments, is committed to developing a world-class healthcare ecosystem in India through R&D, software, services, and manufacturing,” said Bharath Sesha, Managing Director, Philips Indian Subcontinent.
The new Azurion system features enhanced imaging solutions and an easy-to-reposition ergonomic gantry to improve clinicians’ efficiency in delivering accurate patient treatments. This focus on better imaging and operational yield underscores Philips’ commitment to improving patient care in India. In doing so, the Azurion system brings benefit not only to the interventionalists who can treat more patients with high efficiency and potentially better outcomes but also enhances the level of satisfaction for the staff and patients and helps to make a positive impact by keeping the overall expenses of healthcare under control.
“Philips Innovation Campus has been evolving steadily, and I can confidently state that today, we are seen as drivers of the end-to-end innovation value chain. This implies that we have been able to collectively work towards value creation for our businesses globally, harnessing our well-established software capabilities along with deep Artificial Intelligence in the healthcare domain. Further, being a microcosm of Philips global business helps us to accelerate innovations by leveraging our cross-businesses and cross-functional teams within and co-create with teams outside of India as well. The new Azurion system is an outcome of such a collaborative effort. Our teams are also continuously engaging with healthcare leaders and technicians to develop solutions that can address the unique healthcare challenges in India and around the world,” said Arvind Vaishnav, Head of Philips Innovation Campus and Innovation Partnerships – Growth region, Philips.
“It was interesting to see innovative solutions at Philips recently. I am particularly looking forward to the potentially game-changing Direct-to-Angio-Suite (DTAS) feature. This innovative technology will revolutionize stroke care by significantly reducing door-to-puncture time, thereby improving patient outcomes and saving lives. The new Azurion evidently has advanced capabilities and will enable the interventionalist to provide more efficient and effective treatment, enhancing the quality of life of patients,” said Dr. Santhosh Joseph, Senior Consultant & Clinical Lead, Neuro Interventional, KIMSHEALTH, Trivandrum.
“As an interventionalist, it gives me immense delight to see technologies evolving so rapidly, especially in treating percutaneous coronary interventions, which is generally termed the narrowing of heart arteries. Technologies developed by Philips in this space, which many of us recently experienced, can potentially help interventionalists like us to dramatically decrease contrast and optimize radiation dose administration during the procedure, ensuring both the safety and quality of PCI,” said Dr. T.S. Kler, Chairman & HOD, BLK-Max Heart & Vascular Institute, BLK-Max Super Speciality Hospital, Delhi.
To read more on Philips’s new Azurion system, click here.
